— "Infuriating to see misinformation mongers being taken seriously" by Amanda D'Ambrosio Pierre Kory, MD, one of the most vocal proponents of ivermectin for COVID-19, has the support of Simon & Schuster, with the leading publishing house slated to distribute his...
— ACTIV-6 trial shows no time-to-recovery benefit with anti-parasitic in mild-to-moderate disease by Ed Susman There were no differences in relief from mild-to-moderate COVID-19 symptoms for patients on ivermectin versus placebo, according to the...
By Salim S. Abdool Karim, M.B., Ch.B., Ph.D., and Nikita Devnarain, Ph.D. In practicing evidence-based medicine, physicians use the best evidence currently available on safety and efficacy in making decisions on treatment choices for their patients. During the...
By Carolyn T. Bramante, M.D., M.P.H., et al. Abstract BACKGROUND Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic....
A new clinical trial is the largest to date testing the antiparasitic drug on people with Covid. By Carl Zimmer The antiparasite drug ivermectin does not meaningfully reduce the time needed to recover from Covid, according to a large study posted online Sunday....
Many states in the U.S. have been moving forward with legislation making the “controversial” medication ivermectin available over the counter, allowing physicians to prescribe the drug and pharmacists to dispense the medication without suffering a legal penalty....
“At some point it will become a waste of resources to continue studying an unpromising approach,” one expert said. By Carl Zimmer The anti-parasitic drug ivermectin, which has surged in popularity as an alternative treatment for Covid-19 despite a lack of...
By Gilmar Reis, M.D., Ph.D., et al. Abstract BACKGROUND The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by...
Tennessee appears to be the latest state moving forward with two bills to allow people to purchase ivermectin as an alternative treatment for COVID-19. One bill, SB 2746, is being proposed by Republican State Representative Susan Lynn, and...
The French biotech company MedinCell announced it has treated the first participants in the SAIVE study last week, the 400-participant, multicenter, randomized, double-blind, placebo-controlled study with an independent Data Monitoring Committee, conducted...
By F. Perry Wilson, MD, MSCE Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine If you took a random sample of 100 people from around the world, eight of them would have these...
Similar bills are working their way through the legislature in Oklahoma, Missouri, Indiana, Arizona, and Alaska. By Sophie Mann New Hampshire's GOP-led House has passed a bill that would allow pharmacists to dispense Ivermectin under a standard order, meaning...
By Mary Beth Pfeiffer On Tuesday, March 1, 2022, I received an email from Twitter. It seems I had violated policy “on spreading misleading and potentially harmful information related to COVID-19.” Without ceremony or meaningful due process, Twitter suspended my...
Is Ivermectin a miracle or a menace against COVID-19? It's a miracle vs. onchocerciasis. COVID? A new study suggests ivermectin is not great. By Joe Graedon Let me be perfectly honest. I love ivermectin. Is ivermectin a miracle? Absolutely! It has saved the...
Big Pharma influences high-impact journals to selectively publish (purportedly) negative studies while outright rejecting positive studies from publication. JAMA did it again yesterday. By Pierre Kory, MD, MPA One of the main corporate disinformation tactics used to...